IM Cannabis (IMCC) Interest & Investment Income (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Interest & Investment Income of $179271.6 for Q4 2025, down 85.41% year-over-year from $1.2 million in Q4 2024, and down 77.79% quarter-over-quarter from $807291.5 in Q3 2025.
IM Cannabis (IMCC) Interest & Investment Income (2020 - 2026) Analysis & Trends
IM Cannabis' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $179271.6 for Q4 2025.
- In Q4 2025, Interest & Investment Income fell 85.41% year-over-year to $179271.6; the TTM figure through Dec 2025 stood at $3.6 million (up 187.39% YoY), while the FY2025 annual figure was $2.5 million, up 52.35% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $179271.6, down from $807291.5 in the prior quarter.
- The five-year high for Interest & Investment Income was $6.5 million in Q3 2021, with the low at -$10389.6 in Q1 2024.
- The 5-year median for Interest & Investment Income is $1.4 million (2021), against an average of $2.1 million.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income sank 100.4% in 2024, then soared 110027.24% in 2025.
- IM Cannabis' Interest & Investment Income stood at $1.5 million in 2021, then soared by 65.56% to $2.5 million in 2022, then climbed by 3.16% to $2.6 million in 2023, then slumped by 52.96% to $1.2 million in 2024, then tumbled by 85.41% to $179271.6 in 2025.
- Business Quant data shows IMCC's Interest & Investment Income at $179271.6 in Q4 2025, $807291.5 in Q3 2025, and $1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | IM Cannabis | 535,526.41 | -633,443.76 | 1.09 Mn | 415,682.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 415,682.03 |
| Dec 31, 2025 | 179,271.57 |
| Sep 30, 2025 | 807,291.49 |
| Jun 30, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 733.05 |
| Jun 30, 2024 | 25,589.92 |
| Mar 31, 2024 | -10,389.58 |
| Mar 31, 2023 | 2.61 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 6.53 Mn |
| Jun 30, 2021 | 5.05 Mn |
| Mar 31, 2021 | 5.71 Mn |
| Dec 31, 2020 | -115,058.20 |
| Sep 30, 2020 | 890,002.47 |
| Jun 30, 2020 | 146,404.40 |
| Mar 31, 2020 | 167,080.39 |